RhumbLine Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260M | Buy |
|
|||||
|
2025
Q1 | $253M | Sell |
|
|||||
|
2024
Q4 | $215M | Sell |
|
|||||
|
2024
Q3 | $198M | Sell |
|
|||||
|
2024
Q2 | $169M | Sell |
|
|||||
|
2024
Q1 | $180M | Sell |
|
|||||
|
2023
Q4 | $229M | Sell |
|
|||||
|
2023
Q3 | $214M | Buy |
|
|||||
|
2023
Q2 | $215M | Sell |
|
|||||
|
2023
Q1 | $232M | Buy |
|
|||||
|
2022
Q4 | $235M | Buy |
|
|||||
|
2022
Q3 | $166M | Buy |
|
|||||
|
2022
Q2 | $139M | Buy |
|
|||||
|
2022
Q1 | $127M | Buy |
|
|||||
|
2021
Q4 | $153M | Buy |
|
|||||
|
2021
Q3 | $144M | Sell |
|
|||||
|
2021
Q2 | $147M | Sell |
|
|||||
|
2021
Q1 | $146M | Sell |
|
|||||
|
2020
Q4 | $139M | Sell |
|
|||||
|
2020
Q3 | $159M | Sell |
|
|||||
|
2020
Q2 | $194M | Buy |
|
|||||
|
2020
Q1 | $168M | Buy |
|
|||||
|
2019
Q4 | $143M | Buy |
|
|||||
|
2019
Q3 | $138M | Buy |
|
|||||
|
2019
Q2 | $144M | Sell |
|
|||||
|
2019
Q1 | $139M | Buy |
|
|||||
|
2018
Q4 | $131M | Buy |
|
|||||
|
2018
Q3 | $161M | Sell |
|
|||||
|
2018
Q2 | $150M | Sell |
|
|||||
|
2018
Q1 | $177M | Sell |
|
|||||
|
2017
Q4 | $173M | Buy |
|
|||||
|
2017
Q3 | $188M | Sell |
|
|||||
|
2017
Q2 | $165M | Buy |
|
|||||
|
2017
Q1 | $153M | Buy |
|
|||||
|
2016
Q4 | $158M | Buy |
|
|||||
|
2016
Q3 | $171M | Buy |
|
|||||
|
2016
Q2 | $173M | Sell |
|
|||||
|
2016
Q1 | $191M | Buy |
|
|||||
|
2015
Q4 | $209M | Sell |
|
|||||
|
2015
Q3 | $205M | Buy |
|
|||||
|
2015
Q2 | $241M | Sell |
|
|||||
|
2015
Q1 | $245M | Sell |
|
|||||
|
2014
Q4 | $241M | Sell |
|
|||||
|
2014
Q3 | $278M | Sell |
|
|||||
|
2014
Q2 | $222M | Sell |
|
|||||
|
2014
Q1 | $196M | Sell |
|
|||||
|
2013
Q4 | $208M | Sell |
|
|||||
|
2013
Q3 | $181M | Sell |
|
|||||
|
2013
Q2 | $151M | Buy |
|